Publications
(since 2000)
In international reviewed journals:
Traffic Jam at the Bacterial Sec Translocase: Targeting the SecA Nanomotor by Small-Molecule Inhibitors.
|
Development of a high-throughput screening assay for the discovery of small-molecule SecA inhibitors.
|
Synthesis and antibacterial evaluation of a novel series of 2-(1,2-dihydro-3-oxo-3H-pyrazol-2-yl)benzothiazoles.
|
Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.
|
Synthesis of novel 5-amino-thiazolo[4,5-d]pyrimidines as E. coli and S. aureus SecA inhibitors.
|
Cloning and expression vectors for a Gram-positive host, Streptomyces lividans.
|
Amino acid uptake profiling of wild type and recombinant Streptomyces lividans TK24 batch fermentations.
|
The Streptomyces coelicolor genome encodes a type I ribosome-inactivating protein.
|
The role of fimV and the importance of its tandem repeat copy number in twitching motility, pigment production, and morphology in Legionella pneumophila.
|
Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon.
|
Assessment of adaptive focused acoustics versus manual vortex/freeze-thaw for intracellular metabolite extraction from Streptomyces lividans producing recombinant proteins using GC-MS and multi-block principal component analysis.
|
A Legionella pneumophila collagen-like protein encoded by a gene with a variable number of tandem repeats is involved in the adherence and invasion of host cells.
|
Selection and characterization of DNA aptamers for egg white lysozyme.
|
High complexity of Plasmodium vivax infections in symptomatic patients from a rural community in central Vietnam detected by microsatellite genotyping.
|
Human Plasmodium knowlesi infections in young children in central Vietnam.
|
Evaluation of the type I signal peptidase as antibacterial target for biofilm-associated infections of Staphylococcus epidermidis.
|
An easy and fast method for the evaluation of Staphylococcus epidermidis type I signal peptidase inhibitors.
|
Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB - implications for the search for novel antibiotics.
|
Secretory production of recombinant proteins by Streptomyces.
|
Twitching motility in Legionella pneumophila.
|
Characterization of the posttranscriptional modifications in Legionella pneumophila small-subunit ribosomal RNA.
|
Intragenic tandem repeat variation between Legionella pneumophila strains.
|
The importance of the twin-arginine translocation pathway for bacterial virulence.
|
Characterization of the Streptomyces lividans PspA response.
|
Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems. Genet
|
A faster and more accurate assay for intracellular replication of Legionella pneumophila in amoebae hosts. J
|
Abstract The role of protein secretion systems in the virulence of the intracellular pathogen Legionella pneumophila.
|
Legionella pneumophila exhibits plasminogen activator activity.
|
Evidence for the Presence of Legionella Bacteriophages in Environmental Water Samples.
|
Differential 2-D protein gel electrophoresis analysis of Legionella pneumophila wild type and Tat secretion mutants.
|
Recombinant production of Streptococcus equisimilis streptokinase by Streptomyces lividans.
|
Post-transcriptional modification mapping in the Clostridium acetobutylicum 16S rRNA by mass spectrometry and reverse transcriptase assays.
|
The Tat pathway in Streptomyces lividans: interaction of Tat subunits and their role in translocation.
|
The twin-arginine translocation pathway is necessary for correct membrane insertion of the Rieske Fe/S protein in Legionella pneumophila.
|
pspA overexpression in Streptomyces lividans improves both Sec- and Tat-dependent protein secretion.
|
Effect of iron on the expression of sirR and sitABC in biofilm-associated Staphylococcus epidermidis.
|
| The type II signal peptidase of Legionella pneumophila.
|
Evaluation of TatABC overproduction on Tat- and Sec-dependent protein secretion in Streptomyces lividans.
|
The use of clostridial spores for cancer treatment.
|
Detection and quantification of Legionella pneumophila in water samples using competitive PCR.
|
| Compensatory effect of the minor Streptomyces lividans type I signal peptidases on the SipY major signal peptidase deficiency as determined by extracellular proteome analysis.
|
Surface plasmon resonance-based interaction studies reveal competition of Streptomyces lividans type I signal peptidases for binding preproteins.
|
Clostridium spores as anti-tumour agents.
|
| Functional large-scale production of a novel Jonesia sp. xyloglucanase by heterologous secretion from Streptomyces lividans.
|
Inactivation of the 20S proteasome in Streptomyces lividans and its influence on the production of heterologous proteins.
|
Functional analysis of TatA and TatB in Streptomyces lividans.
|
| Legionella pneumophila Philadelphia-1 tatB and tatC affect intracellular replication and biofilm formation.
|
| Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment.
|
| Structural organization of the twin-arginine translocation system in Streptomyces lividans.
|
| First proteomic analysis of Legionella pneumophila based on its developing genome sequence.
|
Complete genomic nucleotide sequence and analysis of the temperate bacteriophage VWB.
|
Clostridium-mediated transfer system of therapeutic proteins to solid tumors: increased heterologous protein production.
|
| Type I signal peptidases of Gram-positive bacteria.
|
Protein secretion in Legionella pneumophila and its relation to virulence.
|
The use of the cMyc epitope tag can be problematic for protein detection in Legionella pneumophila.
|
Comparison of the Sec and Tat secretion pathways for heterologous protein production by Streptomyces lividans.
|
Isolation of high quality RNA from Streptomyces.
|
| Molecular and functional characterisation of type I signal peptidase from Legionella pneumophila.
|
A putative twin-arginine translocation pathway in Legionella pneumophila.
|
| Analysis of type I signal peptidase affinity and specificity for preprotein substrates.
|
| The importance of the Tat-dependent protein secretion pathway in Streptomyces as revealed by phenotypic changes in tat deletion mutants and genome analysis.
|
Leader peptidases with an emphasis on Gram-positive bacteria.
|
Non-invasive (19)F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours.
|
Expression of biologically active human tumor necrosis factor beta by Streptomyces lividans.
|
Tumour-specific gene delivery using genetically engineered bacteria.
|
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions.
|
Improved PCR-based method for the direct screening of Streptomyces transformants.
|
Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella Typhimurium.
|
Evidence for SipY as the major type I signal peptidase of Streptomyces lividans.
|
Clostridium spores for tumor-specific delivery of drugs.
|
Physical requirements for the in vitro processing of the Streptomyces lividans signal peptidases.
|
Anaerobic bacteria as a tumor-specific delivery system of therapeutic proteins.
|
Evidence or a functional twin-arginine mediated secretion pathway in Streptomyces.
|
Modification of radio-inducibility of Clostridium promoters by insertion or deletion of the Cheo box.
|
Evidence of substrate preference between the Streptomyces lividans type I signal peptidases.
|
Radioresponse recA promotes significantly increases TNFa production in recombinant clostridia after 2 Gy irradiation.
|
Membrane topology of the Streptomyces lividans type I signal peptidases.
|
Efficient isolation of total RNA from Clostridium without DNA contamination.
|
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.
|
The use of radio-induced bacterial promoters in anaerobic conditions: a means to control gene-expression in Clostridium-mediated therapy for cancer.
|
Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters.
|
In vivo anti-tumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.
|
Protein secretion biotechnology using Streptomyces lividans: large-scale production of functional trimeric tumor necrosis factor a.
|
Vascular targeting of solid tumours - a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas.
|
The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase.
|
Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumours of different growth.
|
The HIV-1 reverse transcription (RT) process as target for RT inhibitors.
|
Fidelity analysis of HIV-1 reverse transcriptase mutants with an altered amino acid sequence at residue Leu 74, Gln 89, Tyr 183 and Tyr 115.
|
Book chapters written:
Clostridia: special heterologous expression systems for prokaryotic and eukaryotic proteins
|
Tumor-specific gene therapy delivery with engineered bacteria. In press
|
"Cancer Gene Therapy" Bacterial Systems.
|
Clostridium-mediated transfer of therapeutic proteins to solid tumors: an alternative to gene-therapy approaches.
|
Gram-positive bacteria for the heterologous production of biopharmaceutical compounds.
|
Recombinant clostridia in Cancer Therapy.
|

